Literature DB >> 8914243

Isolated zygomycosis in a bought living unrelated kidney transplant.

K J Stas1, P G Louwagie, B J Van Damme, W Coosemans, M Waer, Y F Vanrenterghem.   

Abstract

We report the first case of zygomycosis by Absidia corymbifera, only localized in an unrelated living donor kidney was bought and transplanted in India. Zygomycosis was diagnosed 2.5 months post-transplantation, in the clinical setting of rapid transplant failure, following an episode of cytomegalovirus (CMV) colitis, CMV nephritis, and acute rejection. Treatment consisted of transplantectomy. One year later, the patient is doing well, without clinical or serological evidence of persistent mycotic or virological infections. We speculate that this isolated mycotic infection originated with the donor or was due to the poor hygienic conditions in the operating theater or surgical ward. Another possibility is that this isolated renal involvement resulted from a subclinical pulmonary infection with hematogenous dissemination to the kidney in a manner comparable to renal tuberculosis. The patient received no amphotericin and was cured with transplantectomy alone.

Entities:  

Mesh:

Year:  1996        PMID: 8914243     DOI: 10.1007/bf00335563

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  10 in total

1.  Transplant tourism: understanding the risks.

Authors:  Jennifer M Babik; Peter Chin-Hong
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

Review 2.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

3.  Mucormycosis and acute kidney injury.

Authors:  Krishan L Gupta; Aakriti Gupta
Journal:  J Nephropathol       Date:  2012-10-01

4.  Isolated renal mucormycosis after liver transplantation:an unusual case report.

Authors:  B Geramizadeh; K Kazemi; A R Shamsaifar; A Bahraini; S Nikeghbalian; S A Malekhosseini
Journal:  Iran Red Crescent Med J       Date:  2012-07-30       Impact factor: 0.611

5.  Mucormycosis (zygomycosis) of renal allograft.

Authors:  Krishan L Gupta; Kusum Joshi; Harbir S Kohli; Vivekanand Jha; Vinay Sakhuja
Journal:  Clin Kidney J       Date:  2012-11-08

6.  Renal mucormycosis: a rare and potentially lethal complication of kidney transplantation.

Authors:  Sreyram Kuy; Chun He; David C Cronin
Journal:  Case Rep Transplant       Date:  2013-10-22

7.  Isolated bilateral renal mucormycosis in apparently immunocompetent patients-a case series from India and review of the literature.

Authors:  Dharmendra Bhadauria; Praveen Etta; Anand Chelappan; Mohan Gurjar; Anupma Kaul; Raj Kumar Sharma; Amit Gupta; Narayan Prasad; Rungmei S Marak; Manoj Jain; Aneesh Srivastava; Hira Lal
Journal:  Clin Kidney J       Date:  2018-06-02

Review 8.  Mucormycosis co-infection in COVID-19 patients: An update.

Authors:  Abdullah S Alkhamiss; Ahmed A Ahmed; Zafar Rasheed; Ruqaih Alghsham; Ali Shariq; Thamir Alsaeed; Sami A Althwab; Suliman Alsagaby; Abdullah S M Aljohani; Fahad A Alhumaydhi; Sharifa K Alduraibi; Alaa K Alduraibi; Homaidan T Alhomaidan; Khaled S Allemailem; Raya A Alharbi; Samar A Alamro; Arwa M Alqusayer; Sahim A Alharbi; Thekra A Alharby; Mona S Almujaydil; Ayman M Mousa; Sultan A Alghaniam; Abdulrhman A Alghunaim; Rana Alghamdi; Nelson Fernández; Waleed Al Abdulmonem
Journal:  Open Life Sci       Date:  2022-08-10       Impact factor: 1.311

9.  Mucormycosis of the Thyroid Gland: A Cataclysmic Event in Renal Allograft Recipient.

Authors:  N Prasad; R Manjunath; D Bhadauria; R S K Marak; R K Sharma; V Agarwal; M Jain; A Gupta
Journal:  Indian J Nephrol       Date:  2018 May-Jun

Review 10.  Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.

Authors:  Shreya Dogra; Akanksha Arora; Aashni Aggarwal; Gautam Passi; Akanksha Sharma; Gurpal Singh; Ravi P Barnwal
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.